Stay updated with breaking news from Responsibility Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NORTHAMPTON, MA / ACCESSWIRE / May 4, 2023 / Pentair Karla Robertson highlighted the positive impacts made in 2022 during Pentair's Global Town Hall in May 2023.As published on the Pentair BlogBy Karla
Diluted 224,271 223,501 Earnings per share - basic ... | May 4, 2023
04.05.2023 - NORTHAMPTON, MA / ACCESSWIRE / May 4, 2023 / Pentair Karla Robertson highlighted the positive impacts made in 2022 during Pentair's Global Town Hall in May 2023.As published on the Pentair BlogBy Karla Robertson, Pentair Executive Vice President, ...
Dosed first patient in the global Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE)Expects to complete enrollment in the Phase 2 study of NTLA-2002 in 2H 2023Plans to submit IND
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, today published its 2022 Corporate Responsibility Report. This year’s edition reasserts our commitment to advancing pioneering RNAi science and supporting health equity.